Edmond de Rothschild Holding’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Edmond de Rothschild Holding’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-188	Closed	-$5K	–	911
2016 Q3	$5K	Hold	188	–	–	﹤0.01%	812
2016 Q2	$5K	Hold	188	–	–	﹤0.01%	784
2016 Q1	$5K	Sell	188 -1,250	-87%	-$33.9K	﹤0.01%	785
2015 Q4	$53K	Buy	1,438 +63	+5%	+$2.78K	﹤0.01%	626
2015 Q3	$67K	Sell	1,375 -500	-27%	-$34.9K	﹤0.01%	595
2015 Q2	$129K	Buy	+1,875	New	+$86.8K	﹤0.01%	534

Other funds holding ANTH

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Edmond de Rothschild Holding's ANTH Position: Q4 2016 in Review

Edmond de Rothschild Holding sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q4 2016, closing a stake of 188 shares — an estimated $5K sold.

Edmond de Rothschild Holding first reported a position in ANTH in Q2 2015 and held it in 6 quarters. The position peaked at $129K in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q4 2016.

Edmond de Rothschild Holding reported no remaining Anthera Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Edmond de Rothschild Holding sold 188 Anthera Pharmaceuticals, Inc. shares in Q4 2016, an estimated $5K.
Edmond de Rothschild Holding first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 6 quarters.
Edmond de Rothschild Holding's Anthera Pharmaceuticals, Inc. position peaked at $129K in Q2 2015.
72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2016.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2016, filed 14 Feb 2017.